Business Daily Media

Business Marketing

Eisai to Present Abstracts on Lenvatinib at 2021 Gastrointestinal Cancers Symposium

  • Written by ACN Newswire - Press Releases

Eisai to Present Abstracts on Lenvatinib at 2021 Gastrointestinal Cancers Symposium

TOKYO, Jan 12, 2021 - (JCN Newswire) - Eisai Co., Ltd. has announced that presentations on a series of abstracts highlighting updates on its in-house discovered lenvatinib mesylate (product name: LENVIMA, the orally available kinase inhibitor, "lenvatinib") will be given at the Gastrointestinal Cancers Symposium Virtual Meeting, from January 15

Read more //?#

Popular

Could Business Asset Finance Be Your Solution During COVID?

Small business owners are increasingly looking at alternative solutions for financing during COVID times. Is business asset finance a viable option? In a rare turn for 2020, the news lately has been looking up. Fears of a...

Why it is so important for Companies to understand their team members financial wellness

In a survey conducted by CoreData, they found that only 6% of employees they surveyed, classified themselves as ‘superstar savers’. This section was defined as having no concerns about their ability to pay their mortgage or ...

Why empathy is the key to effective leadership in business

If everyone was the same, we’d live in a very boring world. The beauty of humanity is in our differences. It just so happens that these differences can be very good for business: diverse companies generate 2.5x more cash per ...

Virtual Office
Tomorrow Business Growth